Never miss the latest news and offers - subscribe now!
Many biopharmaceutical therapies, such as mAbs and blood plasma factors, are produced using biological materials. This carries the risk that microorganisms such as viral contaminants may be unintentionally introduced into the manufacturing process and contaminate the product. Thus of paramount importance is the removal of such adventitious agents using effective viral filtration methods.
In this webinar, the fundamental principles of virus filtration as well as its practical execution will be discussed. In addition, participants will gain an in-depth understanding of filterability, validation and the local regulatory framework surrounding virus filtration processes. By the conclusion of the session, all attendees should be able to conduct a virus filterability trial and will be well equipped to have appropriate discussions with validation labs.
Meet the authors from the ‘Insights on Successful Gene Therapy Manufacturing and Commercialization’ ebook